Your browser doesn't support javascript.
loading
Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations.
Kuramitsu, Madoka; Momose, Haruka; Uchida, Yuichiro; Ishitsuka, Kenji; Kubota, Ryuji; Tokunaga, Masahito; Utsunomiya, Atae; Umekita, Kunihiko; Hashikura, Yuuki; Nosaka, Kisato; Koh, Ki-Ryang; Nakamura, Hitomi; Sagara, Yasuko; Sobata, Rieko; Satake, Masahiro; Nagata, Koh; Hasegawa, Yuri; Sasaki, Daisuke; Hasegawa, Hiroo; Sato, Tomoo; Yamano, Yoshihisa; Hiraga, Kou; Tezuka, Kenta; Ikebe, Emi; Matsuoka, Sahoko; Okuma, Kazu; Watanabe, Toshiki; Miura, Kiyonori; Hamaguchi, Isao.
Afiliación
  • Kuramitsu M; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Momose H; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Uchida Y; Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University , Kagoshima, Japan.
  • Ishitsuka K; Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University , Kagoshima, Japan.
  • Kubota R; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University , Kagoshima, Japan.
  • Tokunaga M; Department of Hematology, Imamura General Hospital , Kagoshima, Japan.
  • Utsunomiya A; Department of Hematology, Imamura General Hospital , Kagoshima, Japan.
  • Umekita K; Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki , Miyazaki, Japan.
  • Hashikura Y; Department of Clinical Laboratory, University of Miyazaki Hospital , Miyazaki, Japan.
  • Nosaka K; Department of Clinical Laboratory, University of Miyazaki Hospital , Miyazaki, Japan.
  • Koh K-R; Cancer Center, Kumamoto University Hospital , Kumamoto, Japan.
  • Nakamura H; Department of Hematology, Osaka General Hospital of West Japan Railway Company , Osaka, Japan.
  • Sagara Y; Japanese Red Cross Kyushu Block Blood Center , Fukuoka, Japan.
  • Sobata R; Japanese Red Cross Kyushu Block Blood Center , Fukuoka, Japan.
  • Satake M; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society , Tokyo, Japan.
  • Nagata K; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society , Tokyo, Japan.
  • Hasegawa Y; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.
  • Sasaki D; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.
  • Hasegawa H; Department of Laboratory Medicine, Nagasaki University Hospital , Nagasaki, Japan.
  • Sato T; Department of Laboratory Medicine, Nagasaki University Hospital , Nagasaki, Japan.
  • Yamano Y; Department of Neurology, St. Marianna University School of Medicine , Kanagawa, Japan.
  • Hiraga K; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine , Kanagawa, Japan.
  • Tezuka K; Department of Neurology, St. Marianna University School of Medicine , Kanagawa, Japan.
  • Ikebe E; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine , Kanagawa, Japan.
  • Matsuoka S; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Okuma K; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Watanabe T; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Miura K; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases , Tokyo, Japan.
  • Hamaguchi I; Department of Microbiology, Faculty of Medicine, Kansai Medical University , Osaka, Japan.
Microbiol Spectr ; 11(6): e0207823, 2023 Dec 12.
Article en En | MEDLINE | ID: mdl-37966220
IMPORTANCE: The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data are available for only approximately 1.5 billion people worldwide. The point-of-care test is a powerful tool for the easy and quick detection of infections without the requirement for expensive instruments and laboratory equipment. Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test that was evaluated in this study, might significantly advance our understanding of the global epidemiology of HTLV-1 infection.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Virus Linfotrópico T Tipo 1 Humano / Infecciones por HTLV-I Límite: Humans Idioma: En Revista: Microbiol Spectr Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Virus Linfotrópico T Tipo 1 Humano / Infecciones por HTLV-I Límite: Humans Idioma: En Revista: Microbiol Spectr Año: 2023 Tipo del documento: Article País de afiliación: Japón